{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:04:28Z","timestamp":1793315068548,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-MSX0597"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0597"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["cstc2020jcyj-zdxmX0002"],"award-info":[{"award-number":["cstc2020jcyj-zdxmX0002"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Personnel Bureau","award":["2021XM2055"],"award-info":[{"award-number":["2021XM2055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-024-01736-5","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T03:44:28Z","timestamp":1726112668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases"],"prefix":"10.1186","volume":"16","author":[{"given":"Man","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"24","key":"1736_CR1","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1111\/febs.15776","volume":"288","author":"NK Karamanos","year":"2021","unstructured":"Karamanos NK, Theocharis AD, Piperigkou Z, et al. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021;288(24):6850\u2013912.","journal-title":"FEBS J"},{"key":"1736_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cbpa.2019.08.001","volume":"53","author":"MW Kirkness","year":"2019","unstructured":"Kirkness MW, Lehmann K, Forde NR. Mechanics and structural stability of the collagen triple helix. Curr Opin Chem Biol. 2019;53:98\u2013105.","journal-title":"Curr Opin Chem Biol"},{"issue":"6","key":"1736_CR3","doi-asserted-by":"publisher","first-page":"062005","DOI":"10.1088\/1748-605X\/ac2b79","volume":"16","author":"W Kong","year":"2021","unstructured":"Kong W, Lyu C, Liao H, Du Y. Collagen crosslinking: effect on structure, mechanics and fibrosis progression. Biomed Mater. 2021;16(6):062005.","journal-title":"Biomed Mater"},{"issue":"7835","key":"1736_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587(7835):555\u201366.","journal-title":"Nature"},{"key":"1736_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","volume":"65","author":"R Weiskirchen","year":"2019","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Asp Med. 2019;65:2\u201315.","journal-title":"Mol Asp Med"},{"issue":"3","key":"1736_CR6","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020;217(3):e20190103.","journal-title":"J Exp Med"},{"key":"1736_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.matbio.2018.03.007","volume":"68\u201369","author":"Y Ramazani","year":"2018","unstructured":"Ramazani Y, Knops N, Elmonem MA, et al. Connective tissue growth factor (CTGF) from basics to clinics. Matrix Biol. 2018;68\u201369:44\u201366.","journal-title":"Matrix Biol"},{"issue":"1","key":"1736_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13578-022-00856-w","volume":"12","author":"X Zhao","year":"2022","unstructured":"Zhao X, Chen J, Sun H, Zhang Y, Zou D. New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP\u2013ECM interaction. Cell Biosci. 2022;12(1):117.","journal-title":"Cell Biosci"},{"issue":"6","key":"1736_CR9","doi-asserted-by":"publisher","first-page":"C1110","DOI":"10.1152\/ajpcell.00121.2022","volume":"322","author":"M Ilieva","year":"2022","unstructured":"Ilieva M, Uchida S. Epitranscriptomics in fibroblasts and fibrosis. Am J Physiol Cell Physiol. 2022;322(6):C1110\u20136.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1736_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105910","volume":"173","author":"T Xue","year":"2021","unstructured":"Xue T, Qiu X, Liu H, et al. Epigenetic regulation in fibrosis progress. Pharmacol Res. 2021;173: 105910.","journal-title":"Pharmacol Res"},{"key":"1736_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110224","volume":"92","author":"L Yang","year":"2022","unstructured":"Yang L, Liu Y, Sun Y, Huang C, Li J, Wang Y. New advances of DNA\/RNA methylation modification in liver fibrosis. Cell Signal. 2022;92: 110224.","journal-title":"Cell Signal"},{"issue":"20","key":"1736_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1177\/15353702221128564","volume":"247","author":"L Xu","year":"2022","unstructured":"Xu L, Zhou L, Yan C, Li L. Emerging role of N6-methyladenosine RNA methylation in lung diseases. Exp Biol Med (Maywood). 2022;247(20):1862\u201372.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1736_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119186","volume":"271","author":"X Li","year":"2021","unstructured":"Li X, Yang Y, Chen S, Zhou J, Li J, Cheng Y. Epigenetics-based therapeutics for myocardial fibrosis. Life Sci. 2021;271: 119186.","journal-title":"Life Sci"},{"issue":"10","key":"1736_CR14","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A. 1974;71(10):3971\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1736_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/genes12071019","volume":"12","author":"A Maldonado L\u00f3pez","year":"2021","unstructured":"Maldonado L\u00f3pez A, Capell BC. The METTL3-m(6)A epitranscriptome: dynamic regulator of epithelial development, differentiation, and cancer. Genes (Basel). 2021;12(7):1019.","journal-title":"Genes (Basel)"},{"key":"1736_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4\u201327.","journal-title":"Adv Drug Deliv Rev"},{"issue":"20","key":"1736_CR17","doi-asserted-by":"publisher","first-page":"10901","DOI":"10.1021\/jacs.3c00713","volume":"145","author":"X Li","year":"2023","unstructured":"Li X, Zhang Q, Yu SM, Li Y. The chemistry and biology of collagen hybridization. J Am Chem Soc. 2023;145(20):10901\u201316.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"1736_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, Xu H, Wang W, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17(1):309.","journal-title":"J Transl Med"},{"key":"1736_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106449","volume":"184","author":"EJ Calabrese","year":"2022","unstructured":"Calabrese EJ, Dhawan G, Kapoor R, Agathokleous E, Calabrese V. Hormesis: wound healing and fibroblasts. Pharmacol Res. 2022;184: 106449.","journal-title":"Pharmacol Res"},{"key":"1736_CR20","doi-asserted-by":"publisher","first-page":"4586569","DOI":"10.1155\/2022\/4586569","volume":"2022","author":"H Qian","year":"2022","unstructured":"Qian H, Shan Y, Gong R, et al. Fibroblasts in scar formation: biology and clinical translation. Oxid Med Cell Longev. 2022;2022:4586569.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"1736_CR21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.stem.2022.07.006","volume":"29","author":"HE Talbott","year":"2022","unstructured":"Talbott HE, Mascharak S, Griffin M, Wan DC, Longaker MT. Wound healing, fibroblast heterogeneity, and fibrosis. Cell Stem Cell. 2022;29(8):1161\u201380.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"1736_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/path.4104","volume":"229","author":"F Klingberg","year":"2013","unstructured":"Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229(2):298\u2013309.","journal-title":"J Pathol"},{"key":"1736_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","volume":"68\u201369","author":"M Roderfeld","year":"2018","unstructured":"Roderfeld M. Matrix metalloproteinase functions in hepatic injury and fibrosis. Matrix Biol. 2018;68\u201369:452\u201362.","journal-title":"Matrix Biol"},{"key":"1736_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","volume":"44\u201346","author":"S Duarte","year":"2015","unstructured":"Duarte S, Baber J, Fujii T, Coito AJ. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 2015;44\u201346:147\u201356.","journal-title":"Matrix Biol"},{"issue":"1","key":"1736_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/biom12010094","volume":"12","author":"Z Guler","year":"2022","unstructured":"Guler Z, Roovers JP. Role of fibroblasts and myofibroblasts on the pathogenesis and treatment of pelvic organ prolapse. Biomolecules. 2022;12(1):94.","journal-title":"Biomolecules"},{"issue":"13","key":"1736_CR26","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1093\/nar\/gkab378","volume":"49","author":"S Oerum","year":"2021","unstructured":"Oerum S, Meynier V, Catala M, Tisn\u00e9 C. A comprehensive review of m6A\/m6Am RNA methyltransferase structures. Nucleic Acids Res. 2021;49(13):7239\u201355.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"1736_CR27","first-page":"1233","volume":"3","author":"JA Bokar","year":"1997","unstructured":"Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3(11):1233\u201347.","journal-title":"RNA"},{"issue":"7608","key":"1736_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang X, Feng J, Xue Y, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016;534(7608):575\u20138.","journal-title":"Nature"},{"issue":"2","key":"1736_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306\u201317.","journal-title":"Mol Cell"},{"issue":"2","key":"1736_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93\u20135.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"1736_CR31","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","volume":"24","author":"E Sch\u00f6ller","year":"2018","unstructured":"Sch\u00f6ller E, Weichmann F, Treiber T, et al. Interactions, localization, and phosphorylation of the m(6)A generating METTL3-METTL14-WTAP complex. RNA. 2018;24(4):499\u2013512.","journal-title":"RNA"},{"issue":"2","key":"1736_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177\u201389.","journal-title":"Cell Res"},{"issue":"12","key":"1736_CR33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885\u20137.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"1736_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18\u201329.","journal-title":"Mol Cell"},{"issue":"1","key":"1736_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1736_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27(3):315\u201328.","journal-title":"Cell Res"},{"issue":"9","key":"1736_CR37","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27(9):1115\u201327.","journal-title":"Cell Res"},{"issue":"3","key":"1736_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285\u201395.","journal-title":"Nat Cell Biol"},{"key":"1736_CR39","doi-asserted-by":"publisher","first-page":"e31311","DOI":"10.7554\/eLife.31311","volume":"6","author":"IA Roundtree","year":"2017","unstructured":"Roundtree IA, Luo GZ, Zhang Z, et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. eLife. 2017;6:e31311.","journal-title":"eLife"},{"key":"1736_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.114215","volume":"247","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gu P, Xie Y, et al. Insights into the mechanism underlying crystalline silica-induced pulmonary fibrosis via transcriptome-wide m(6)A methylation profile. Ecotoxicol Environ Saf. 2022;247: 114215.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"12","key":"1736_CR41","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1016\/j.ymthe.2021.06.008","volume":"29","author":"JX Zhang","year":"2021","unstructured":"Zhang JX, Huang PJ, Wang DP, et al. m(6)A modification regulates lung fibroblast-to-myofibroblast transition through modulating KCNH6 mRNA translation. Mol Ther. 2021;29(12):3436\u201348.","journal-title":"Mol Ther"},{"issue":"2","key":"1736_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/toxsci\/kfab133","volume":"185","author":"J Ning","year":"2022","unstructured":"Ning J, Du H, Zhang Y, et al. N6-methyladenosine modification of CDH1 mRNA promotes PM2.5-induced pulmonary fibrosis via mediating epithelial mesenchymal transition. Toxicol Sci. 2022;185(2):143\u201357.","journal-title":"Toxicol Sci"},{"issue":"5","key":"1736_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1165\/rcmb.2021-0379OC","volume":"66","author":"S Wang","year":"2022","unstructured":"Wang S, Luo W, Huang J, et al. The combined effects of circular RNA methylation promote pulmonary fibrosis. Am J Respir Cell Mol Biol. 2022;66(5):510\u201323.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1736_CR44","doi-asserted-by":"publisher","first-page":"114755","DOI":"10.1016\/j.ecoenv.2023.114755","volume":"254","author":"D Ji","year":"2023","unstructured":"Ji D, Hu C, Ning J, et al. N(6)-methyladenosine mediates Nrf2 protein expression involved in PM2.5-induced pulmonary fibrosis. Ecotoxicol Environ Saf. 2023;254:114755.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1736_CR45","doi-asserted-by":"publisher","first-page":"2425065","DOI":"10.1155\/2022\/2425065","volume":"2022","author":"MS Deng","year":"2022","unstructured":"Deng MS, Chen KJ, Zhang DD, Li GH, Weng CM, Wang JM. m6A RNA methylation regulators contribute to predict and as a therapy target of pulmonary fibrosis. Evid Based Complement Altern Med. 2022;2022:2425065.","journal-title":"Evid Based Complement Altern Med"},{"key":"1736_CR46","doi-asserted-by":"publisher","first-page":"131791","DOI":"10.1016\/j.jhazmat.2023.131791","volume":"457","author":"J Ning","year":"2023","unstructured":"Ning J, Pei Z, Wang M, et al. Site-specific Atg13 methylation-mediated autophagy regulates epithelial inflammation in PM2.5-induced pulmonary fibrosis. J Hazard Mater. 2023;457:131791.","journal-title":"J Hazard Mater"},{"issue":"1","key":"1736_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11658-022-00329-5","volume":"27","author":"W Sun","year":"2022","unstructured":"Sun W, Li Y, Ma D, et al. ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1. Cell Mol Biol Lett. 2022;27(1):26.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"1736_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17435390.2019.1661041","volume":"14","author":"B Han","year":"2020","unstructured":"Han B, Chu C, Su X, et al. N(6)-methyladenosine-dependent primary microRNA-126 processing activated PI3K-AKT-mTOR pathway drove the development of pulmonary fibrosis induced by nanoscale carbon black particles in rats. Nanotoxicology. 2020;14(1):1\u201320.","journal-title":"Nanotoxicology"},{"issue":"2","key":"1736_CR49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201903169R","volume":"35","author":"T Li","year":"2021","unstructured":"Li T, Zhuang Y, Yang W, et al. Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts. FASEB J. 2021;35(2): e21162.","journal-title":"FASEB J"},{"issue":"Pt A","key":"1736_CR50","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ijbiomac.2022.11.042","volume":"223","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Song K, Tu B, et al. METTL3 boosts glycolysis and cardiac fibroblast proliferation by increasing AR methylation. Int J Biol Macromol. 2022;223(Pt A):899\u2013915.","journal-title":"Int J Biol Macromol"},{"key":"1736_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175494","volume":"942","author":"JF Ding","year":"2023","unstructured":"Ding JF, Sun H, Song K, et al. IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis. Eur J Pharmacol. 2023;942: 175494.","journal-title":"Eur J Pharmacol"},{"key":"1736_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106840","volume":"194","author":"B Tu","year":"2023","unstructured":"Tu B, Song K, Zhou Y, et al. METTL3 boosts mitochondrial fission and induces cardiac fibrosis by enhancing LncRNA GAS5 methylation. Pharmacol Res. 2023;194: 106840.","journal-title":"Pharmacol Res"},{"issue":"3","key":"1736_CR53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/genes14030591","volume":"14","author":"H Cheng","year":"2023","unstructured":"Cheng H, Li L, Xue J, Ma J, Ge J. TNC accelerates hypoxia-induced cardiac injury in a METTL3-dependent manner. Genes (Basel). 2023;14(3):591.","journal-title":"Genes (Basel)"},{"issue":"3","key":"1736_CR54","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201734R","volume":"37","author":"Y Zhuang","year":"2023","unstructured":"Zhuang Y, Li T, Hu X, et al. MetBil as a novel molecular regulator in ischemia-induced cardiac fibrosis via METTL3-mediated m6A modification. FASEB J. 2023;37(3): e22797.","journal-title":"FASEB J"},{"issue":"4","key":"1736_CR55","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.118.033794","volume":"139","author":"P Mathiyalagan","year":"2019","unstructured":"Mathiyalagan P, Adamiak M, Mayourian J, et al. FTO-Dependent N(6)-methyladenosine regulates cardiac function during remodeling and repair. Circulation. 2019;139(4):518\u201332.","journal-title":"Circulation"},{"key":"1736_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.702579","volume":"9","author":"W Ju","year":"2021","unstructured":"Ju W, Liu K, Ouyang S, Liu Z, He F, Wu J. Changes in N6-methyladenosine modification modulate diabetic cardiomyopathy by reducing myocardial fibrosis and myocyte hypertrophy. Front Cell Dev Biol. 2021;9: 702579.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"1736_CR57","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s12265-022-10209-0","volume":"15","author":"XX Li","year":"2022","unstructured":"Li XX, Mu B, Li X, Bie ZD. circCELF1 inhibits myocardial fibrosis by regulating the expression of DKK2 through FTO\/m(6)A and miR-636. J Cardiovasc Transl Res. 2022;15(5):998\u20131009.","journal-title":"J Cardiovasc Transl Res"},{"key":"1736_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.954769","volume":"10","author":"K Liu","year":"2022","unstructured":"Liu K, Ju W, Ouyang S, et al. Exercise training ameliorates myocardial phenotypes in heart failure with preserved ejection fraction by changing N6-methyladenosine modification in mice model. Front Cell Dev Biol. 2022;10: 954769.","journal-title":"Front Cell Dev Biol"},{"key":"1736_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2023.06.001","volume":"181","author":"V Kmietczyk","year":"2023","unstructured":"Kmietczyk V, Oelschl\u00e4ger J, Gupta P, et al. Ythdf2 regulates cardiac remodeling through its mRNA target transcripts. J Mol Cell Cardiol. 2023;181:57\u201366.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"1736_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13062-022-00346-6","volume":"17","author":"T Peng","year":"2022","unstructured":"Peng T, Liu M, Hu L, et al. LncRNA Airn alleviates diabetic cardiac fibrosis by inhibiting activation of cardiac fibroblasts via a m6A-IMP2-p53 axis. Biol Direct. 2022;17(1):32.","journal-title":"Biol Direct"},{"issue":"2","key":"1736_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113505","volume":"424","author":"T Kang","year":"2023","unstructured":"Kang T, Liu L, Tan F, et al. Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner. Exp Cell Res. 2023;424(2): 113505.","journal-title":"Exp Cell Res"},{"issue":"19","key":"1736_CR62","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2217\/epi-2019-0365","volume":"12","author":"Z Cui","year":"2020","unstructured":"Cui Z, Huang N, Liu L, et al. Dynamic analysis of m6A methylation spectroscopy during progression and reversal of hepatic fibrosis. Epigenomics. 2020;12(19):1707\u201323.","journal-title":"Epigenomics"},{"issue":"1","key":"1736_CR63","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41420-022-01036-y","volume":"8","author":"B Shu","year":"2022","unstructured":"Shu B, Zhang RZ, Zhou YX, He C, Yang X. METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1\/TGF-\u03b21\/Smad signaling pathway. Cell Death Discov. 2022;8(1):266.","journal-title":"Cell Death Discov"},{"issue":"1","key":"1736_CR64","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41420-021-00756-x","volume":"7","author":"B Shu","year":"2021","unstructured":"Shu B, Zhou YX, Li H, Zhang RZ, He C, Yang X. The METTL3\/MALAT1\/PTBP1\/USP8\/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis. Cell Death Discov. 2021;7(1):368.","journal-title":"Cell Death Discov"},{"issue":"12","key":"1736_CR65","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1016\/j.ymthe.2022.07.020","volume":"30","author":"Y Li","year":"2022","unstructured":"Li Y, Kang X, Zhou Z, et al. The m(6)A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis. Mol Ther. 2022;30(12):3714\u201328.","journal-title":"Mol Ther"},{"issue":"Pt 2","key":"1736_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.121887","volume":"331","author":"W Li","year":"2023","unstructured":"Li W, Tan M, Wang H, et al. METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury. Environ Pollut. 2023;331(Pt 2): 121887.","journal-title":"Environ Pollut"},{"issue":"1","key":"1736_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12192-019-01034-7","volume":"25","author":"Y Feng","year":"2020","unstructured":"Feng Y, Hu Y, Hou Z, Sun Q, Jia Y, Zhao R. Chronic corticosterone exposure induces liver inflammation and fibrosis in association with m(6)A-linked post-transcriptional suppression of heat shock proteins in chicken. Cell Stress Chaperones. 2020;25(1):47\u201356.","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"1736_CR68","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jcmgh.2021.05.007","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, Dong H, Sun B, et al. METTL3\/METTL14 transactivation and m6A-dependent TGF-\u03b21 translation in activated Kupffer cells. Cell Mol Gastroenterol Hepatol. 2021;12(3):839\u201356.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"11","key":"1736_CR69","doi-asserted-by":"publisher","first-page":"14371","DOI":"10.1096\/fj.202001337R","volume":"34","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Pan X, Du N, et al. ASIC1a regulates miR-350\/SPRY2 by N(6) -methyladenosine to promote liver fibrosis. FASEB J. 2020;34(11):14371\u201388.","journal-title":"FASEB J"},{"issue":"1","key":"1736_CR70","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000004","volume":"7","author":"J Wang","year":"2023","unstructured":"Wang J, Du M, Meng L, et al. Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1. Hepatol Commun. 2023;7(1): e0004.","journal-title":"Hepatol Commun"},{"key":"1736_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.996245","volume":"13","author":"H Gao","year":"2022","unstructured":"Gao H, Wang X, Ma H, et al. METTL16 regulates m(6)A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis. Front Genet. 2022;13: 996245.","journal-title":"Front Genet"},{"key":"1736_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102151","volume":"47","author":"M Shen","year":"2021","unstructured":"Shen M, Li Y, Wang Y, et al. N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells. Redox Biol. 2021;47: 102151.","journal-title":"Redox Biol"},{"key":"1736_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.767051","volume":"9","author":"C Fan","year":"2021","unstructured":"Fan C, Ma Y, Chen S, et al. Comprehensive analysis of the transcriptome-wide m6A methylation modification difference in liver fibrosis mice by high-throughput m6A sequencing. Front Cell Dev Biol. 2021;9: 767051.","journal-title":"Front Cell Dev Biol"},{"key":"1736_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.146125","volume":"813","author":"A Wei","year":"2022","unstructured":"Wei A, Zhao F, Hao A, Liu B, Liu Z. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) mitigates the liver fibrosis via WTAP\/m(6)A\/Ptch1 axis through Hedgehog pathway. Gene. 2022;813: 146125.","journal-title":"Gene"},{"key":"1736_CR75","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2022.02.028","volume":"182","author":"M Shen","year":"2022","unstructured":"Shen M, Guo M, Li Y, et al. m(6)A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells. Free Radic Biol Med. 2022;182:246\u201359.","journal-title":"Free Radic Biol Med"},{"key":"1736_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106608","volume":"187","author":"J Wang","year":"2023","unstructured":"Wang J, Yang Y, Sun F, et al. ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation. Pharmacol Res. 2023;187: 106608.","journal-title":"Pharmacol Res"},{"key":"1736_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174900","volume":"922","author":"JJ Yang","year":"2022","unstructured":"Yang JJ, Wang J, Yang Y, et al. ALKBH5 ameliorated liver fibrosis and suppressed HSCs activation via triggering PTCH1 activation in an m(6)A dependent manner. Eur J Pharmacol. 2022;922: 174900.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1736_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1198","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhou P, Deng Y, et al. ALKBH5-mediated m(6) A demethylation of TIRAP mRNA promotes radiation-induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma. Clin Transl Med. 2023;13(2): e1198.","journal-title":"Clin Transl Med"},{"issue":"5","key":"1736_CR79","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41418-023-01130-3","volume":"30","author":"Y Feng","year":"2023","unstructured":"Feng Y, Guo S, Zhao Y, et al. DNA 5mC and RNA m(6)A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression. Cell Death Differ. 2023;30(5):1211\u201320.","journal-title":"Cell Death Differ"},{"key":"1736_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102378","volume":"54","author":"R Sun","year":"2022","unstructured":"Sun R, Tian X, Li Y, et al. The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. Redox Biol. 2022;54: 102378.","journal-title":"Redox Biol"},{"key":"1736_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106704","volume":"189","author":"L Chen","year":"2023","unstructured":"Chen L, Xia S, Wang F, et al. m(6)A methylation-induced NR1D1 ablation disrupts the HSC circadian clock and promotes hepatic fibrosis. Pharmacol Res. 2023;189: 106704.","journal-title":"Pharmacol Res"},{"issue":"14","key":"1736_CR82","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2217\/epi-2020-0126","volume":"12","author":"X Li","year":"2020","unstructured":"Li X, Fan X, Yin X, Liu H, Yang Y. Alteration of N(6)-methyladenosine epitranscriptome profile in unilateral ureteral obstructive nephropathy. Epigenomics. 2020;12(14):1157\u201373.","journal-title":"Epigenomics"},{"issue":"16","key":"1736_CR83","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.1111\/jcmm.16603","volume":"25","author":"E Liu","year":"2021","unstructured":"Liu E, Lv L, Zhan Y, et al. METTL3\/N6-methyladenosine\/miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1\/ERK\/NF-\u03baB pathway activation. J Cell Mol Med. 2021;25(16):7660\u201374.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"1736_CR84","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202202012RRR","volume":"37","author":"Y Sun","year":"2023","unstructured":"Sun Y, Ge J, Shao F, et al. Long noncoding RNA AI662270 promotes kidney fibrosis through enhancing METTL3-mediated m(6) A modification of CTGF mRNA. FASEB J. 2023;37(8): e23071.","journal-title":"FASEB J"},{"issue":"6","key":"1736_CR85","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.18632\/aging.102950","volume":"12","author":"P Liu","year":"2020","unstructured":"Liu P, Zhang B, Chen Z, et al. m(6)A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145\/FAK pathway. Aging (Albany NY). 2020;12(6):5280\u201399.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"1736_CR86","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12882-022-02753-3","volume":"23","author":"W Tang","year":"2022","unstructured":"Tang W, Zhao Y, Zhang H, Peng Y, Rui Z. METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy. BMC Nephrol. 2022;23(1):124.","journal-title":"BMC Nephrol"},{"key":"1736_CR87","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00592-023-02145-5","volume":"60","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhang Z, Zheng D, Yi P, Wang S. METTL14 promotes the development of diabetic kidney disease by regulating m(6)A modification of TUG1. Acta Diabetol. 2023;60:1567.","journal-title":"Acta Diabetol"},{"key":"1736_CR88","doi-asserted-by":"publisher","first-page":"1094556","DOI":"10.3389\/fimmu.2022.1094556","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Li Q, Ling Y, et al. m6A eraser FTO modulates autophagy by targeting SQSTM1\/P62 in the prevention of canagliflozin against renal fibrosis. Front Immunol. 2022;13:1094556.","journal-title":"Front Immunol"},{"issue":"12","key":"1736_CR89","doi-asserted-by":"publisher","first-page":"105620","DOI":"10.1016\/j.isci.2022.105620","volume":"25","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen J, Lu Y, et al. TWIK-related acid-sensitive K(+) channel 2 promotes renal fibrosis by inducing cell-cycle arrest. iScience. 2022;25(12):105620.","journal-title":"iScience"},{"key":"1736_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.156000","volume":"159","author":"X Li","year":"2022","unstructured":"Li X, Li Y, Wang Y, He X. The m(6)A demethylase FTO promotes renal epithelial-mesenchymal transition by reducing the m(6)A modification of lncRNA GAS5. Cytokine. 2022;159: 156000.","journal-title":"Cytokine"},{"key":"1736_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.579265","volume":"11","author":"Y Ning","year":"2020","unstructured":"Ning Y, Chen J, Shi Y, et al. Genistein ameliorates renal fibrosis through regulation snail via m6A RNA demethylase ALKBH5. Front Pharmacol. 2020;11: 579265.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1736_CR92","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41467-023-36747-y","volume":"14","author":"J Chen","year":"2023","unstructured":"Chen J, Xu C, Yang K, et al. Inhibition of ALKBH5 attenuates I\/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment. Nat Commun. 2023;14(1):1161.","journal-title":"Nat Commun"},{"issue":"2","key":"1736_CR93","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100172RR","volume":"36","author":"J Xing","year":"2022","unstructured":"Xing J, He YC, Wang KY, Wan PZ, Zhai XY. Involvement of YTHDF1 in renal fibrosis progression via up-regulating YAP. FASEB J. 2022;36(2): e22144.","journal-title":"FASEB J"},{"key":"1736_CR94","doi-asserted-by":"publisher","first-page":"mjad005","DOI":"10.1093\/jmcb\/mjad005","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen Y, Liang J, et al. METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition. J Mol Cell Biol. 2023;15:mjad005.","journal-title":"J Mol Cell Biol."},{"issue":"9","key":"1736_CR95","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1111\/jcmm.16476","volume":"25","author":"X Ma","year":"2021","unstructured":"Ma X, Long C, Wang F, et al. METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt\/\u03b2-catenin pathway. J Cell Mol Med. 2021;25(9):4220\u201334.","journal-title":"J Cell Mol Med"},{"issue":"172","key":"1736_CR96","first-page":"115","volume":"34","author":"J Sun","year":"2022","unstructured":"Sun J, Liu G, Chen R, et al. PARP1 is upregulated by hyperglycemia via N6-methyladenosine modification and promotes diabetic retinopathy. Discov Med. 2022;34(172):115\u201329.","journal-title":"Discov Med"},{"issue":"5","key":"1736_CR97","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jop.13292","volume":"51","author":"X Li","year":"2022","unstructured":"Li X, Gao Y, Chen W, et al. N6-methyladenosine modification contributes to arecoline-mediated oral submucosal fibrosis. J Oral Pathol Med. 2022;51(5):474\u201382.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"1736_CR98","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.joca.2022.01.002","volume":"30","author":"L Xiao","year":"2022","unstructured":"Xiao L, Hu B, Ding B, et al. N(6)-methyladenosine RNA methyltransferase like 3 inhibits extracellular matrix synthesis of endplate chondrocytes by downregulating sex-determining region Y-Box transcription factor 9 expression under tension. Osteoarthr Cartil. 2022;30(4):613\u201325.","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"1736_CR99","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2019.05.168","volume":"516","author":"Q Liu","year":"2019","unstructured":"Liu Q, Li M, Jiang L, Jiang R, Fu B. METTL3 promotes experimental osteoarthritis development by regulating inflammatory response and apoptosis in chondrocyte. Biochem Biophys Res Commun. 2019;516(1):22\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1736_CR100","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12860-022-00444-3","volume":"23","author":"J Gao","year":"2022","unstructured":"Gao J, Li Y, Liu Z, Wang D, Zhang H. Acetaminophen changes the RNA m6A levels and m6A-related proteins expression in IL-1\u03b2-treated chondrocyte cells. BMC Mol Cell Biol. 2022;23(1):45.","journal-title":"BMC Mol Cell Biol"},{"key":"1736_CR101","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.reth.2023.01.005","volume":"22","author":"B Hu","year":"2023","unstructured":"Hu B, Zou X, Yu Y, Jiang Y, Xu H. METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3. Regen Ther. 2023;22:148\u201359.","journal-title":"Regen Ther"},{"issue":"4","key":"1736_CR102","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/15384101.2022.2125751","volume":"22","author":"L Li","year":"2023","unstructured":"Li L, Wang B, Zhou X, et al. METTL3-mediated long non-coding RNA MIR99AHG methylation targets miR-4660 to promote bone marrow mesenchymal stem cell osteogenic differentiation. Cell Cycle. 2023;22(4):476\u201393.","journal-title":"Cell Cycle"},{"issue":"23","key":"1736_CR103","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2217\/epi-2021-0369","volume":"13","author":"L Shen","year":"2021","unstructured":"Shen L, Yu Y, Jiang M, Zhao J. Alteration of the m(6)A methylation landscape in a mouse model of scleroderma. Epigenomics. 2021;13(23):1867\u201383.","journal-title":"Epigenomics"},{"issue":"1","key":"1736_CR104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21037\/atm-22-6021","volume":"11","author":"S Ren","year":"2023","unstructured":"Ren S, Ji Y, Wang M, Ye M, Huang L, Cai X. The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1. Ann Transl Med. 2023;11(1):15.","journal-title":"Ann Transl Med"},{"key":"1736_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.748703","volume":"9","author":"SY Liu","year":"2021","unstructured":"Liu SY, Wu JJ, Chen ZH, et al. The m(6)A RNA modification modulates gene expression and fibrosis-related pathways in hypertrophic scar. Front Cell Dev Biol. 2021;9: 748703.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"1736_CR106","first-page":"1556","volume":"26","author":"J Han","year":"2021","unstructured":"Han J, Du S, Wu C, et al. METTL3 participates in glioma development by regulating the methylation level of COL4A1. J BUON. 2021;26(4):1556\u201362.","journal-title":"J BUON"},{"key":"1736_CR107","doi-asserted-by":"publisher","first-page":"4320809","DOI":"10.1155\/2022\/4320809","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y, Li X, Deng M, Ye C, Peng Y, Lu Y. Cancer-associated fibroblasts hinder lung squamous cell carcinoma oxidative stress-induced apoptosis via METTL3 mediated m(6)A methylation of COL10A1. Oxid Med Cell Longev. 2022;2022:4320809.","journal-title":"Oxid Med Cell Longev"},{"key":"1736_CR108","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fonc.2020.01126","volume":"10","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng C, Jin Y, et al. Reduced expression of METTL3 promotes metastasis of triple-negative breast cancer by m6A methylation-mediated COL3A1 up-regulation. Front Oncol. 2020;10:1126.","journal-title":"Front Oncol"},{"issue":"6","key":"1736_CR109","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s13577-021-00587-z","volume":"34","author":"YT Chen","year":"2021","unstructured":"Chen YT, Xiang D, Zhao XY, Chu XY. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m(6)A methylation promotes disease progression and sorafenib resistance. Hum Cell. 2021;34(6):1800\u201311.","journal-title":"Hum Cell"},{"issue":"3","key":"1736_CR110","first-page":"1012","volume":"10","author":"E Li","year":"2020","unstructured":"Li E, Wei B, Wang X, Kang R. METTL3 enhances cell adhesion through stabilizing integrin \u03b21 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma. Am J Cancer Res. 2020;10(3):1012\u201325.","journal-title":"Am J Cancer Res"},{"key":"1736_CR111","first-page":"892","volume":"10","author":"S Li","year":"2023","unstructured":"Li S, Hu W, Gong S, et al. The Role of PRRC2B in Cerebral Vascular Remodeling Under Acute Hypoxia in Mice. Adv Sci (Weinh). 2023;10:892.","journal-title":"Adv Sci (Weinh)."}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01736-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-024-01736-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01736-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:03:42Z","timestamp":1726113822000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-024-01736-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1186\/s13148-024-01736-5","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"2 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"127"}}